Market News

Stock Alert for Vermillion Inc. (VRML)

Vermillion Inc. (VRML) and its subsidiaries engage in the discovery, development, and commercialization of diagnostics tests that help physicians to diagnose and treat patients. The Company develops novel diagnostic tests in the fields of oncology, hematology, cardiology, and women’s health with the initial focus on ovarian cancer. Its lead product includes the OVA1 ovarian tumor triage test (the OVA1 Test), - Continue Reading »

Stock Alert for XOMA Corp. (XOMA)

XOMA Corp. (XOMA) engages in the discovery and development of innovative antibody therapeutics. The Company’s lead antibody drug candidate is gevokizumab (XOMA 052), a humanized antibody that modulates the inflammatory cytokine interleukin-1 beta, or IL-1 beta. In collaboration with the Company’s partner, Les Laboratoires Servier (Servier), XOMA expects to initiate global Phase III clinical development of gevokizumab to treat non-infectious - Continue Reading »

Stock Alert for Opnext Inc. (NASDAQ: OPXT)

Opnext Inc. (OPXT) designs and manufactures optical components, modules and subsystems for communications uses. The Company sells its products, which enables network connectivity to address the data usage by the global population, to other businesses. Additionally, it sells infrared and visible light optical devices for industrial and commercial use. Its optical communications components consist of discrete transmitters and receivers typically - Continue Reading »

Stock Alert for Micron Technology Inc. (MU)

Micron Technology Inc. (MU) is a provider of advanced semiconductor solutions. Through its worldwide operations, MU manufactures and markets a full range of DRAM, NAND Flash and NOR Flash memory, as well as other innovative memory technologies, packaging solutions and semiconductor systems for use in leading-edge computing, consumer, networking, embedded and mobile products. - Continue Reading »

Small Cap Stock on Watch: James River Coal Reports Q4 and Full Year 2011 Results

Small Cap Stock on Watch: James River Coal Reports Q4 and Full Year 2011 Results

Shares of James River Coal Co. (NASDAQ: JRCC), a coal producer in Central Appalachia and the Illinois Basin, jumped 8.38% to close Thursday’s session at $6.21 after the company posted its latest financial results. The stock saw volume of over 9.83 million shares, versus the 10-day average of 2.53 million. Over the last 52 weeks, the stock has ranged from - Continue Reading »

Small-Cap Stock Spotlight: Zagg Rises on Strong Earnings Report

Small-Cap Stock Spotlight: Zagg Rises on Strong Earnings Report

Shares of Zagg Inc. (NASDAQ: ZAGG), maker of films, skins, audio and power solutions that protect, personalize and enhance mobile devices, traded as much 12% higher to $11.31 on Tuesday, extending gains for the third day in a row.  The stock saw trading volume hit over 5.22 million shares during the session, versus the 10-day average 1.22 million. ZAGG made - Continue Reading »

Pacific Ethanol Inc. (PEIX) Earnings Run Begins Again Amidst Soaring Crude Prices

Pacific Ethanol Inc. (PEIX) Earnings Run Begins Again Amidst Soaring Crude Prices

Shares of Pacific Ethanol Inc. (NASDAQ: PEIX) jumped as much 30% to reach an intraday high of $1.42 Friday, extending gains into a second day on above-average volume of about 28.22 million shares.  Pacific Ethanol, along with many alternative energy related stocks, saw an interesting spike last week as crude oil rallied to reach $108.50 a barrel. Shares in the - Continue Reading »

Renewable Energy Stock on Watch: FuelCell Energy Inc. (FCEL)

Renewable Energy Stock on Watch: FuelCell Energy Inc. (FCEL)

Shares in FuelCell Energy Inc. (NASDAQ: FCEL), maker of fuel cell power plants, soared as much as 22% in Wednesday trade as investors welcomed the news that the company will form a joint venture with Germany’s Fraunhofer IKTS to develop projects in Europe. FCEL shares have gained 32.6% in the last five days; 71.7% in the last month; and 0.6% - Continue Reading »

Threshold Pharmaceuticals (THLD) Surges on Positive Pancreatic Cancer Drug Study

Threshold Pharmaceuticals (THLD) Surges on Positive Pancreatic Cancer Drug Study

Shares in Threshold Pharmaceuticals (THLD) traded higher on Tuesday after the biotechnology company reported positive results from a study on its drug for advanced pancreatic cancer, TH-302. The stock set a new 52-week high of $6.65 before closing at $5.01, up 41.9% for the day.  Over 28 million shares traded hands during the session, topping the 10-day average of 2.23 - Continue Reading »

InsWeb to sell Majority of its Insurance Lead Generation, Marketing Business Assets

InsWeb to sell Majority of its Insurance Lead Generation, Marketing Business Assets

Shares of InsWeb Corp. (NASDAQ: INSW), an operator of an online insurance marketplace that electronically matches consumers and providers of automobile, property, health, term life, and small business insurance, saw a huge rally in today’s trading after the company announced that it will sell substantially all of its assets relating to its insurance lead generation and marketing business to Bankrate - Continue Reading »